Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 31

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT00898807Phase 3Completed
Citalopram for Agitation in Alzheimer's Disease
AgitationAlzheimer's Disease
Principalinvestigator

Research Network

Collaboration Network

15 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Johns Hopkins University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Lon Schneider, MD

University of Southern California Keck School of Medicine Memory and Aging Center

Related
1 trials

Shared therapeutic areas:

AgitationAlzheimer Disease

Worked with same sponsors:

JHSPH Center for Clinical TrialsNational Institute of Mental Health (NIMH)+1 more
Collaborated on 1 trial
Similarity Score24%

Constantine Lyketsos, MD, MHS

Johns Hopkins University

Related
2 trials

Shared therapeutic areas:

AgitationAlzheimer Disease

Worked with same sponsors:

JHSPH Center for Clinical TrialsNational Institute of Mental Health (NIMH)+1 more
Collaborated on 1 trial
Similarity Score24%

Bruce Pollock, MD

Centre for Addiction and Mental Health

Related
1 trials

Shared therapeutic areas:

AgitationAlzheimer Disease

Worked with same sponsors:

JHSPH Center for Clinical TrialsNational Institute of Mental Health (NIMH)+1 more
Collaborated on 1 trial
Similarity Score24%

Daniel Weintraub, MD

University of Pennsylvania

Related
4 trials

Shared therapeutic areas:

AgitationAlzheimer Disease

Worked with same sponsors:

JHSPH Center for Clinical TrialsNational Institute of Mental Health (NIMH)+1 more
Collaborated on 1 trial
Similarity Score24%

Anton Porsteinsson, MD

University of Rochester

Related
1 trials

Shared therapeutic areas:

AgitationAlzheimer Disease

Worked with same sponsors:

JHSPH Center for Clinical TrialsNational Institute of Mental Health (NIMH)+1 more
Collaborated on 1 trial
Similarity Score24%

Davengere Devanand, MD

Columbia University

Related
1 trials

Shared therapeutic areas:

AgitationAlzheimer Disease

Worked with same sponsors:

JHSPH Center for Clinical TrialsNational Institute of Mental Health (NIMH)+1 more
Collaborated on 1 trial
Similarity Score24%

Jerome Yesavage, MD

Stanford University

Related
2 trials

Shared therapeutic areas:

AgitationAlzheimer Disease

Worked with same sponsors:

JHSPH Center for Clinical TrialsNational Institute of Mental Health (NIMH)+1 more
Collaborated on 1 trial
Similarity Score24%

Jacobo Mintzer, MD

Medical University of South Carolina Alzheimer's Research and Clinical Programs

Related
1 trials

Shared therapeutic areas:

AgitationAlzheimer Disease

Worked with same sponsors:

JHSPH Center for Clinical TrialsNational Institute of Mental Health (NIMH)+1 more
Collaborated on 1 trial
Similarity Score24%

Paul Rosenberg, MD

Johns Hopkins University

Related
4 trials

Shared therapeutic areas:

Alzheimer DiseaseAgitation

Worked with same sponsors:

JHSPH Center for Clinical TrialsNational Institute of Mental Health (NIMH)+1 more
Collaborated on 1 trial
Similarity Score24%

Nicolai Goettel, MD

University Hospital, Basel, Switzerland

Related
8 trials

Shared therapeutic areas:

Alzheimer Disease
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00898807Phase 3PrincipalInvestigator

Citalopram for Agitation in Alzheimer's Disease

AgitationAlzheimer's Disease
Completed

All 1 trials loaded